Chemed Corporation (CHE)
NYSE: CHE · Real-Time Price · USD
549.22
-2.11 (-0.38%)
Nov 20, 2026, 2:18 PM EST - Market open
Chemed Revenue
Chemed had revenue of $690.94M in the quarter ending September 30, 2026, with 10.57% growth. This brings the company's total for the last twelve months to $2.66B, up 5.15% year-over-year. In the year 2025, Chemed had annual revenue of $2.53B with 4.06% growth. That makes Chemed the 4,157th largest company in the world by revenue and 1,128th in the United States.
Revenue (ttm)
$2.66B
Revenue Growth
+5.15%
P/S Ratio
2.69
Revenue / Employee
$168,303
Employees
15,811
Market Cap
7.12B
Revenue by Segment
- VITAS 1.63B 64.4%
- Roto-Rooter 899.88M 35.6%
Fiscal year ended Dec 31, 2025 See the full Chemed breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.53B | 98.69M | 4.06% |
| Dec 31, 2024 | 2.43B | 166.87M | 7.37% |
| Dec 31, 2023 | 2.26B | 129.45M | 6.06% |
| Dec 31, 2022 | 2.13B | -4.30M | -0.20% |
| Dec 31, 2021 | 2.14B | 59.68M | 2.87% |
| Dec 31, 2020 | 2.08B | 141.03M | 7.27% |
| Dec 31, 2019 | 1.94B | 155.91M | 8.75% |
| Dec 31, 2018 | 1.78B | 115.92M | 6.96% |
| Dec 31, 2017 | 1.67B | 89.84M | 5.70% |
| Dec 31, 2016 | 1.58B | 33.49M | 2.17% |
| Dec 31, 2015 | 1.54B | 87.11M | 5.98% |
| Dec 31, 2014 | 1.46B | 42.95M | 3.04% |
| Dec 31, 2013 | 1.41B | -16.71M | -1.17% |
| Dec 31, 2012 | 1.43B | 74.07M | 5.46% |
| Dec 31, 2011 | 1.36B | 75.43M | 5.89% |
| Dec 31, 2010 | 1.28B | 90.31M | 7.59% |
| Dec 31, 2009 | 1.19B | 41.30M | 3.59% |
| Dec 31, 2008 | 1.15B | 48.88M | 4.44% |
| Dec 31, 2007 | 1.10B | 81.47M | 8.00% |
| Dec 31, 2006 | 1.02B | 102.62M | 11.20% |
| Dec 31, 2005 | 915.97M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Fresenius Medical Care AG | 22.12B |
| Universal Health Services | 18.35B |
| DaVita | 14.17B |
| Encompass Health | 6.34B |
| Option Care Health | 5.75B |
| PACS Group | 5.71B |
| The Ensign Group | 5.67B |
| Acadia Healthcare Company | 3.41B |
CHE News
- 11 days ago - Chemed Transcript: UBS Global Healthcare Conference - Transcripts
- 14 days ago - Chemed Corporation Declares Quarterly Dividend of 70 Cents - GlobeNewsWire
- 17 days ago - Chemed management to meet with Oppenheimer - TheFly
- 18 days ago - Chemed Corporation to Present at the UBS 2026 Global Healthcare Conference - GlobeNewsWire
- 22 days ago - Chemed price target raised to $585 from $548 at RBC Capital - TheFly
- 22 days ago - Chemed price target raised to $675 from $650 at UBS - TheFly
- 22 days ago - Chemed price target raised to $625 from $590 at Oppenheimer - TheFly
- 23 days ago - Chemed Earnings Call Transcript: Q3 2026 - Transcripts